FDA Wants Sponsors to Flag Real-World Evidence in INDs

Drug Industry Daily
A A
The FDA may start accepting real-world evidence in support of drug applications, but sponsors need to identify the sources of real-world evidence they’re using in advance, the agency said Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily